The Nasdaq 100 climbed as the FDA approval of a drug targeting Alzheimer’s disease bolstered the biotechnology sector. Asia-Pacific markets look set to open mixed. Bitcoin plunged below $34k mark.
Posted inForex
Nasdaq 100 Rally May Lead Nikkei 225, ASX 200 Higher, Bitcoin Falls